Showing 1271-1280 of 3494 results for "".
Lessons from HBO's Docuseries The Defiant Ones
https://practicaldermatology.com/topics/practice-management/lessons-from-hbos-docuseries-emthe-defiant-onesem/20606/How Dr. Dre and Jimmy Iovine disrupted an industry and made billions.AK Therapy: Real-life Approaches to Combinations on Scientifically Speaking
https://practicaldermatology.com/topics/skin-cancer-photoprotection/ak-therapy-real-life-approaches-to-combinations-on-scientifically-speaking/19913/From serial PDT to novel combinations, specialists describe how they treat AKs in real-world settings. Scientifically Speaking host Joel L. Cohen, MD reviews cases from Neal Bhatia, MD, Michael H. Gold, MD, and George Martin, MD.AK Burden and Progression Risk
https://practicaldermatology.com/topics/skin-cancer-photoprotection/ak-burden-and-progression-risk/20134/Individuals with chronic sun damage are at higher risk of developing AK lesions. It is therefore essential that dermatologists emphasize early sun protection recommendations and address progression risks of AK with their patients. Faced with increasing burden of skin cancers, Joel L. Cohen, MD and AEstrogen and Skin: What Can We Do
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/estrogen-and-skin-what-can-we-do/20123/There’s accumulated evidence that depletion of estrogen with age contributes to the visible signs of skin aging. But dermatologists haven’t had many treatment options—until now. Joel L. Cohen, MD addresses the latest developments in care for estrogen deficient skin.Scientifically Speaking: Rox Anderson, MD Talks Changing Lives Through Inventions
https://practicaldermatology.com/videos/scientifically-speaking/scientifically-speaking-rox-anderson-md-talks-changing-lives-through-inventions/20140/Rox Anderson, MD has been at the forefront of inventions that have shaped the modern practice of dermatology. He discusses his inspirations and his desire to advance patient care. Host Joel L. Cohen, MD talks to him about his latest innovations and a recent recognition.Winning Combinations
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/winning-combinations/19740/When it comes to helping patients achieve a youthful look, it’s all about the journey, Suneel Chilukuri, MD tells host Joel L. Cohen, MD. You need to continuously update treatment recommendations as patients age and take advantage of combining neuromodulators, fillers, skincare, and energy-based devAK Treatment Pearls
https://practicaldermatology.com/topics/skin-cancer-photoprotection/ak-treatment-pearls/19731/Joel Cohen, MD and George Martin, MD go in depth to discuss nuances of treating actinic keratosis in a wide ranging conversation covering the concept of painless PDT and how pretreatment may enhance penetration, an update on ingenol mebutate, and a potential role for combination calcipotriene and 5-Hot Topic: Picture Perfect
https://practicaldermatology.com/topics/practice-management/hot-topic-picture-perfect/19567/Standardizing before and after photos in your practice is a must, explains Todd E. Schlesinger, MD. He sits down with Joel L. Cohen, MD to offer tips on improving the quality of photos from what type of camera to use to standardizing camera settings, the angle of photos, and the backdrop used.Updates from the AAD Annual Meeting in San Diego
https://practicaldermatology.com/topics/practice-management/updates-from-the-aad-annual-meeting-in-san-diego/18332/From cosmetic interventions to therapeutic breakthroughs for common dermatoses, and new technologies for practice, the latest innovations take center stage at the 2018 Annual Meeting of the American Academy of Dermatology. Joel L. Cohen, MD; Yolanda Lenzy, MD, MPH; Junko Takeshita, MD, PhD, MSCE; anNeuromodulators in Medical Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neuromodulators-in-medical-dermatology/18520/Physicians are exploring the effects of botulinum toxins on several medical dermatology conditions. Erin Gilbert, MD talks to Joel Cohen, MD about her experience treating rosacea, and discusses the need for better randomized trials to explore treatment options.